AU1163101A - Diagnostic methods - Google Patents

Diagnostic methods

Info

Publication number
AU1163101A
AU1163101A AU11631/01A AU1163101A AU1163101A AU 1163101 A AU1163101 A AU 1163101A AU 11631/01 A AU11631/01 A AU 11631/01A AU 1163101 A AU1163101 A AU 1163101A AU 1163101 A AU1163101 A AU 1163101A
Authority
AU
Australia
Prior art keywords
diagnostic methods
diagnostic
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11631/01A
Inventor
Gillian Ellison
Lynn Dora Paskins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU1163101A publication Critical patent/AU1163101A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU11631/01A 1999-11-13 2000-11-08 Diagnostic methods Abandoned AU1163101A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9926805.4A GB9926805D0 (en) 1999-11-13 1999-11-13 Diagnostic methods
GB9926805 1999-11-13
PCT/GB2000/004267 WO2001036674A2 (en) 1999-11-13 2000-11-08 Diagnostic methods for detection of prostate disorders

Publications (1)

Publication Number Publication Date
AU1163101A true AU1163101A (en) 2001-05-30

Family

ID=10864423

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11631/01A Abandoned AU1163101A (en) 1999-11-13 2000-11-08 Diagnostic methods

Country Status (3)

Country Link
AU (1) AU1163101A (en)
GB (1) GB9926805D0 (en)
WO (1) WO2001036674A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001245815A1 (en) * 2000-03-15 2001-09-24 Incyte Genomics, Inc. Human immune response proteins
AU2001266790A1 (en) * 2000-06-09 2001-12-24 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
IL157872A0 (en) 2001-03-12 2004-03-28 Monogen Inc A panel for detecting a generic disease state containing a plurality of probes and using cell-based diagnosis
US6537811B1 (en) 2001-08-01 2003-03-25 Isis Pharmaceuticals, Inc. Antisense inhibition of SAP-1 expression
US7741098B2 (en) * 2001-11-27 2010-06-22 Nexyte Ab Production of eukaryotic proteins and nucleic acid molecules in C. elegans
EP1472376A4 (en) * 2002-01-18 2007-03-21 Millennium Pharm Inc Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
US20050037447A1 (en) * 2003-07-08 2005-02-17 Yong-Chuan Wong Protein markers for human benign prostatic hyperplasia (BPH)
ES2611000T3 (en) 2010-07-27 2017-05-04 Genomic Health, Inc. Method to use gene expression to determine the prognosis of prostate cancer
CN110904214B (en) * 2019-12-13 2020-12-15 四川省人民医院 Diagnostic agent, kit and use for diagnosing or aiding in the diagnosis of renal insufficiency or renal injury

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190857B1 (en) * 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
WO1999037811A1 (en) * 1998-01-21 1999-07-29 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease

Also Published As

Publication number Publication date
WO2001036674A2 (en) 2001-05-25
WO2001036674A3 (en) 2002-03-28
GB9926805D0 (en) 2000-01-12

Similar Documents

Publication Publication Date Title
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU6599800A (en) Endoscope
AU5967600A (en) Candystraw
AU4115400A (en) Short-circuiter
AU6335000A (en) Depthimeter
AU7514700A (en) Cyanopiperidines
AU6440900A (en) Homogentisate-dioxygenase
AU2023701A (en) Sketcher
AU2804600A (en) Arylaminoalkylamides
AU1163101A (en) Diagnostic methods
AU5672300A (en) Diagnostic device
AU2699800A (en) Organoceramics
AU4916900A (en) Benzofuranylsulfonates
AU6098300A (en) Follistatin-3
AU3191100A (en) Ligand-bonded complex
AU4561600A (en) Benzofuranylaminoalcohols
AU4416500A (en) Tomographic system
AU2194801A (en) Diagnostic method
AU6000600A (en) Diagnostic method
AU1901801A (en) Glucofuranoses
AU4755800A (en) Diagnostic system
AU6925800A (en) Autogrid analysis
AU4435300A (en) Hula-hoop
AU2582200A (en) Windturbine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase